ProQR Therapeutics N.V. Finance Costs
ProQR Therapeutics N.V. (PRQR) reported Finance Costs of EUR 1.29 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-03-12
| Period end | Finance Costs 1 month | Finance Costs 12 month |
|---|---|---|
| 2025-12-31 | 1.29M EUR 20-F · filed 2026-03-12 | |
| 2024-12-31 | 1.08M EUR 20-F · filed 2026-03-12 | |
| 2023-12-31 | 1.46M EUR 20-F · filed 2026-03-12 | |
| 2022-12-31 | 5.13M EUR 20-F · filed 2025-03-13 | |
| 2021-12-31 | 3.40M EUR 20-F · filed 2024-03-13 | |
| 2020-12-31 | 4.03M EUR 20-F · filed 2023-03-29 | |
| 2019-12-31 | 1.08M EUR 20-F · filed 2022-04-29 | |
| 2019-10-31 | 3.05M EUR 6-K · filed 2021-02-25 |